Skip to main content
Investors
Scibase.com
Open menu
At a Glance
Open link menu
At a Glance
Investment Case
Our Strategy
Market Overview
Results & Reports
Open link menu
Results & Reports
Calendar
Financial Data
The Share
Open link menu
The Share
Shareholders
Insider Transactions
Analysts
Share issues and offer TO2
Share Capital Development
Warrants
Governance
Open link menu
Governance
Management and Board of Directors
Annual General Meeting
Articles of Association
Auditor
Certified Advisor
Committees
ESG - sustainability
Releases
Open link menu
Releases
Subscription Service
EN
Current language English, click to switch language
SV
Switch to Svenska
Search
Search
Search
Search on a site
Please fill out this field
Back
Close menu
Search on a site
Please fill out this field
Close
Feb 13 2023
SciBase resolves on a fully guaranteed rights issue of approximately SEK 79.6 million
Feb 13 2023
Year-end report
Dec 22 2022
Letter from the CEO
Dec 22 2022
Letter from the CEO
Nov 10 2022
Interim report
Dec 15 2022
Nevisense for skin barrier evaluation included in large Australian birth cohort study
Nov 07 2022
SciBase announces collaboration to detect skin barrier dysfunction in infants
Oct 27 2022
New article discusses EIS as a potential clinical measure of skin barrier integrity
Nov 08 2022
SciBase invitation to a webinar on November 10 at 11:00 CET
Nov 08 2022
SciBase CEO Simon Grant gives a comment regarding the collaboration with Johnson & Johnson Consumer Health
Pagination
First page
Previous page
…
Page
13
Page
14
Page
15
Page
16
Current page
17
Page
18
Page
19
Page
20
Page
21
…
Next page
Last page
Subscribe to
Close popup
Left
Right
